Results 231 to 240 of about 412,316 (368)

The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high‐, middle‐ and low‐income countries – A Global Congestive Heart Failure (G‐CHF) study

European Journal of Heart Failure, EarlyView.
Abstract Aims The aim of this study was to describe the prognostic importance of left ventricular ejection fraction (LVEF) versus right ventricular (RV) dilatation and dysfunction in patients with heart failure (HF) from countries of different income levels. Methods and results We enrolled 17 321 participants with HF from 40 countries.
Darryl P. Leong, Philip G. Joseph, Hisham Dokainish, Stefan Störk, John V.V. McMurray, Lisa M. Mielniczuk, Sanjib Kumar Sharma, Andrés Orlandini, Kamilu M. Karaye, Antoni Bayes‐Genis, Tara McCready, Alex Grinvalds, Kumar Balasubramanian, Kelley R. Branch, Kristian Kragholm, Salim Yusuf, on behalf of the G‐CHF Investigators   +16 more
wiley   +1 more source

Digitalis as a Cause of Paroxysmal Atrial Tachycardia with Atrioventricular Block [PDF]

, 1960
S. Oram, Leon Resnekov, Paul S. Davies
openalex   +1 more source

Delayed cardiac consequences unveiled by magnetic resonance imaging in a high‐voltage electric shock survivor

ESC Heart Failure, EarlyView.
Golnaz Houshmand, Majid Sadeghpour, Faezeh Tabesh   +2 more
wiley   +1 more source

Incidence and predictors of weaning failure from veno‐arterial extracorporeal membrane oxygenation therapy in patients with cardiogenic shock

European Journal of Heart Failure, EarlyView.
Predictors of weaning failure from veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) in patients with cardiogenic shock. RRT, renal replacement therapy. Abstract Aims This study aimed to investigate incidence and predictors of weaning failure and in‐hospital death after successful weaning from veno‐arterial extracorporeal membrane oxygenation
Angela Dettling, Caroline Kellner, Jonas Sundermeyer, Benedikt N. Beer, Lisa Besch, Letizia Fausta Bertoldi, Stefan Blankenberg, Jeroen Dauw, Dennis Eckner, Ingo Eitel, Tobias Graf, Patrick Horn, Joanna Jozwiak‐Nozdrzykowska, Paulus Kirchhof, Stefan Kluge, Jannis Krais, Dirk von Lewinski, Axel Linke, Peter Luedike, Enzo Lüsebrink, Peter Nordbeck, Federico Pappalardo, Matthias Pauschinger, Alastair Proudfoot, Tienush Rassaf, Hermann Reichenspurner, Can Martin Sag, Clemens Scherer, P. Christian Schulze, Robert H.G. Schwinger, Carsten Skurk, Marek Sramko, Guido Tavazzi, Holger Thiele, Nuccia Morici, Ephraim B. Winzer, Dirk Westermann, Benedikt Schrage, Norman Mangner   +38 more
wiley   +1 more source

Concept of the five ′A′s for treating emergency arrhythmias

Journal of Emergencies, Trauma and Shock, 2010
Cardiac rhythm disturbances such as bradycardia (heart rate < 50/min) and tachycardia (heart rate > 100/min) require rapid therapeutic intervention.
Trappe Hans-Joachim
doaj  

2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.

Heart Rhythm, 2015
R. Sheldon, B. Grubb, B. Olshansky, W. Shen, Hugh Calkins, M. Brignole, S. Raj, A. Krahn, C. Morillo, J. Stewart, R. Sutton, P. Sandroni, K. Friday, Denise Hachul, M. I. Cohen, D. Lau, K. Mayuga, J. Moak, R. Sandhu, Khalil Kanjwal   +19 more
semanticscholar   +1 more source

ABNORMAL P WAVES AND PAROXYSMAL TACHYCARDIA [PDF]

, 1963
L. G. Davies, I. P. Ross
openalex   +1 more source

Continuous risk monitoring and management of heart failure: Rationale and design of the ALLEVIATE‐HF trial

European Journal of Heart Failure, EarlyView.
Design of the ALLEVIATE‐HF study with schematic of win ratio analysis stratified by left ventricular ejection fraction (LVEF) ≥50% versus LVEF <50%. ∆, change; 6MWT, 6‐min walk test; BNP, B‐type natriuretic peptide; CIED, cardiac implantable electronic device; CV, cardiovascular; EQ‐5D, EuroQol 5‐Dimension Questionnaire; HF, heart failure; ICM ...
Javed Butler, Rami Kahwash, Muhammad Shahzeb Khan, Bart Gerritse, Aimee Laechelt, Jennifer Wehking, Shantanu Sarkar, Brian van Dorn, Verla Laager, Nirav Patel, Michael R. Zile, on behalf of the ALLEVIATE‐HF Investigators   +11 more
wiley   +1 more source

Propranolol in paroxysmal ventricular tachycardia. [PDF]

, 1966
Robert J. Kernohan
openalex   +1 more source

Update on preclinical models of cancer therapy‐related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio‐Oncology, and the ESC Working Group on Cellular Biology of the Heart

European Journal of Heart Failure, EarlyView.
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the ...
Alessandra Ghigo, Pietro Ameri, Aarti Asnani, Edoardo Bertero, Rudolf A. de Boer, Dimitrios Farmakis, Arantxa González, Stephane Heymans, Borja Ibáñez, Teresa López‐Fernández, Alexander R. Lyon, Piero Pollesello, Amina Rakisheva, Konstantinos Stellos, Katrin Streckfuss‐Bömeke, Carlo Gabriele Tocchetti, Thomas Thum, Peter van der Meer, Eva Van Rooij, Piotr Ponikowski, Marco Metra, Giuseppe Rosano, Sophie Van Linthout   +22 more
wiley   +1 more source